Literature DB >> 712635

Hypothermia and the pharmacokinetics and pharmacodynamics of pancuronium in the cat.

R D Miller, S Agoston, F van der Pol, L H Booij, J F Crul, J Ham.   

Abstract

We tested the effect of hypothermia on the pharmacokinetics and pharmacodynamics of pancuronium in the cat. In 14 cats given pancuronium, 120 microgram/kg i.v., we found that neuromuscular block lasted between 2.5 and 3.0 times longer at 29 degrees C (N = 5) than at 34 degrees C (N = 5) or 39 degrees C (N = 4). The apparent plasma elimination half-life was 46 +/- 7 min (S.E.) at 29 degrees C as compared to 21 +/- 2 and 25 +/- 6 min at 34 and 39 degrees C, respectively. The volume of distribution of the central compartment and total volume of distribution at steady state were less at 29 and 34 dgrees C than at 39 degrees C. Total plasma clearance was 4.3 +/- 0.4 ml/kg/min at 29 degrees C and 10.7 +/- 0.9 and 10.9 +/- 1.5 ml/kg/min at 34 and 39 degrees C, respectively. The reduced plasma clearance resulted at least in part from a markedly reduced biliary and urinary excretion of pancuronium at 29 degrees C as compared to 34 and 39 degrees C. In four other cats, the plasma concentration of pancuronium was correlated with depression of twitch tension under steady-state conditions. The ED50 of pancuronium (plasma concentration required for a 50% depression of twitch tension) was 0.035 and 0.073 microgram/ml at 29 and 38 degrees C, respectively. We conclude that a pancuronium neuromuscular block is prolonged at 29 degrees C because of an increased sensitivity of the neuromuscular junction to pancuronium and delayed biliary and urinary excretion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 712635

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

Review 1.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Electromyographic monitoring of profound surgical muscle relaxation during cardiac anesthesia.

Authors:  L Gyermek; G Henderson
Journal:  J Clin Monit       Date:  1992-04

Review 3.  Recent developments with muscles relaxants and their antagonists.

Authors:  R D Miller
Journal:  Can Anaesth Soc J       Date:  1979-03

4.  The kinetics of competitive antagonism of nicotinic acetylcholine receptors at physiological temperature.

Authors:  Deeptankar Demazumder; James P Dilger
Journal:  J Physiol       Date:  2007-12-06       Impact factor: 5.182

Review 5.  Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.

Authors:  Marcel P H van den Broek; Floris Groenendaal; Antoine C G Egberts; Carin M A Rademaker
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 7.  Pharmacokinetics in intravenous anaesthetic practice.

Authors:  P Duvaldestin
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

8.  Localized hypothermia influences assessment of recovery from vecuronium neuromuscular blockade.

Authors:  M L Young; C W Hanson; M J Bloom; J S Savino; S Muravchick
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063

9.  The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.

Authors:  Enno D Wildschut; Annewil van Saet; Pavla Pokorna; Maurice J Ahsman; John N Van den Anker; Dick Tibboel
Journal:  Pediatr Clin North Am       Date:  2012-08-29       Impact factor: 3.278

10.  Pharmacodynamics of doxacurium during cardiac surgery with hypothermic cardiopulmonary bypass.

Authors:  P McDonagh; J Y Dupuis; M Curran; J Kitts; J E Wynands
Journal:  Can J Anaesth       Date:  1996-02       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.